131 related articles for article (PubMed ID: 17292679)
1. ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity.
Horton JK; Stefanick DF; Kedar PS; Wilson SH
DNA Repair (Amst); 2007 Jun; 6(6):742-50. PubMed ID: 17292679
[TBL] [Abstract][Full Text] [Related]
2. Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.
Horton JK; Stefanick DF; Zeng JY; Carrozza MJ; Wilson SH
DNA Repair (Amst); 2011 Feb; 10(2):225-34. PubMed ID: 21130714
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.
Horton JK; Stefanick DF; Naron JM; Kedar PS; Wilson SH
J Biol Chem; 2005 Apr; 280(16):15773-85. PubMed ID: 15701627
[TBL] [Abstract][Full Text] [Related]
4. Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.
Heacock ML; Stefanick DF; Horton JK; Wilson SH
DNA Repair (Amst); 2010 Aug; 9(8):929-36. PubMed ID: 20573551
[TBL] [Abstract][Full Text] [Related]
5. PARP inhibition during alkylation-induced genotoxic stress signals a cell cycle checkpoint response mediated by ATM.
Carrozza MJ; Stefanick DF; Horton JK; Kedar PS; Wilson SH
DNA Repair (Amst); 2009 Nov; 8(11):1264-72. PubMed ID: 19717351
[TBL] [Abstract][Full Text] [Related]
6. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
[TBL] [Abstract][Full Text] [Related]
7. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
Luo Q; Li Y; Deng J; Zhang Z
Chem Biol Interact; 2015 Jan; 226():12-22. PubMed ID: 25499136
[TBL] [Abstract][Full Text] [Related]
8. A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1.
Lu HR; Wang X; Wang Y
Cell Cycle; 2006 Oct; 5(20):2364-70. PubMed ID: 17102615
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
Noël G; Godon C; Fernet M; Giocanti N; Mégnin-Chanet F; Favaudon V
Mol Cancer Ther; 2006 Mar; 5(3):564-74. PubMed ID: 16546970
[TBL] [Abstract][Full Text] [Related]
10. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
Schlicker A; Peschke P; Bürkle A; Hahn EW; Kim JH
Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795
[TBL] [Abstract][Full Text] [Related]
11. Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition.
Kedar PS; Stefanick DF; Horton JK; Wilson SH
DNA Repair (Amst); 2008 Nov; 7(11):1787-98. PubMed ID: 18691676
[TBL] [Abstract][Full Text] [Related]
12. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
Luo Q; Li Y; Lai Y; Zhang Z
J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by the inhibitors of poly(ADP-ribose)polymerase in HeLa cells.
Ghosh U; Bhattacharyya NP
Mol Cell Biochem; 2009 Jan; 320(1-2):15-23. PubMed ID: 18695944
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
García S; Bodaño A; Pablos JL; Gómez-Reino JJ; Conde C
Ann Rheum Dis; 2008 May; 67(5):631-7. PubMed ID: 17890271
[TBL] [Abstract][Full Text] [Related]
15. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.
Godon C; Cordelières FP; Biard D; Giocanti N; Mégnin-Chanet F; Hall J; Favaudon V
Nucleic Acids Res; 2008 Aug; 36(13):4454-64. PubMed ID: 18603595
[TBL] [Abstract][Full Text] [Related]
16. Involvement of poly(ADP-ribose) polymerase activity in regulating Chk1-dependent apoptotic cell death.
Horton JK; Stefanick DF; Wilson SH
DNA Repair (Amst); 2005 Sep; 4(10):1111-20. PubMed ID: 16002346
[TBL] [Abstract][Full Text] [Related]
17. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.
Muñoz-Gámez JA; Quiles-Pérez R; Ruiz-Extremera A; Martín-Álvarez AB; Sanjuan-Nuñez L; Carazo A; León J; Oliver FJ; Salmerón J
Cancer Lett; 2011 Feb; 301(1):47-56. PubMed ID: 21093979
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
20. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
